SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-21-017625
Filing Date
2021-04-05
Accepted
2021-04-05 16:18:47
Documents
5
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 PRE 14A crsp-pre14a_20210610.htm PRE 14A 2358284
2 GRAPHIC gd0v2vp2h1wf000001.jpg GRAPHIC 19505
3 GRAPHIC gd0v2vp2h1wf000004.jpg GRAPHIC 114026
4 GRAPHIC gd0v2vp2h1wf000002.jpg GRAPHIC 23992
5 GRAPHIC gd0v2vp2h1wf000003.jpg GRAPHIC 129565
  Complete submission text file 0001564590-21-017625.txt   2755260
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37923 | Film No.: 21805588
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences